IU School of Medicine findings set new standard for use of blood-based biomarkers in clinical trials for prediction of cancer recurrence

Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women’s blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.

IU School of Medicine  |  Jul 09, 2020

Research news, faculty and student life

Explore the IU School of Medicine expertise hubs and blogs for information about the world-renowned medical education and research programs at this academic medical center. Hear from faculty experts on their areas of expertise, learn what medical education is really like at IU School of Medicine's statewide campuses, and get a sense for the working and learning environment of the school.

See All Blogs

For the Media

Reporters, bloggers and other members of the media can access current news about advancements being made by the most knowledgeable experts in today’s most critical areas of medicine by contacting the IU School of Medicine Dean’s Office of Strategic Communication. This team can help set up interviews, provide photos and graphics, and fulfill other information needs.

Contact Communication Team

Fact Sheet

IUSM-MedStud-ResPosters-201605.jpg

Campus News 

Each IU School of Medicine campus offers a high-quality medical education with an integrated curriculum, access to leading medical research and clinical resources, and a rich campus life.